Su, Helen C., M.D., Ph.D.
individual record
Investigator
Positions:
- Investigator, Human Immunological Diseases Unit, LHD
overview
Helen Su received M.D. and Ph.D. degrees from Brown University. She completed training in pediatrics at St. Louis Children’s Hospital, Washington University, and subspecialty training in allergy and immunology at NIAID. After postdoctoral training with Michael Lenardo, M.D., in the Laboratory of Immunology, she joined the Laboratory of Host Defenses in 2007 as a tenure-track clinical investigator.
selected publications
Articles4
- (2017). Dedicator of cytokinesis 8-deficient CD4(+) T cells are biased to a T(H)2 effector fate at the expense of T(H)1 and T(H)17 cells. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 139(3), 933-949.
- (2017). Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. JOURNAL OF EXPERIMENTAL MEDICINE. 214(1), 91-106.
- (2014). Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. SCIENCE. 345(6204), 1623-1627.
-
Academic Articles87
- (2020). Autoantibodies against type I IFNs in patients with life-threatening COVID-19. SCIENCE. 370(6515), 423-+.
- (2020). Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. SCIENCE. 370(6515), 422-+.
- (2020). Migration-induced cell shattering due to DOCK8 deficiency causes a type 2-biased helper T cell response. NATURE IMMUNOLOGY.
-
- (2020). Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?. NATURE REVIEWS IMMUNOLOGY. 20(8), 455-456.